LONDON, Nov. 13, 2017 -- The global cell culture market will grow at a CAGR of 10.7% from 2017 to 2022 to reach USD 21,058 million by 2022, according to the latest publication by Meticulous Research™. This market is driven by increase in the life science research, advancement in cell based technology, increasing prevalence of various chronic diseases, rising demand for cell based therapies, and increasing cell based production. However, high cost of cell culture research and high risk of contamination have embraced the growth of cell culture market globally. Further, handling and optimization of protocol for in vitro studies pose a great challenge for the growth of this market.
North America holds the major share in the global cell culture market, followed by Europe, Asia-Pacific owing to the increased funding in medical research, drug development regulations which demand cell culture products, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech industry. However, Asia-Pacific region possesses lucrative growth potential for cell culture market during the forecast period.
Get a sample report on http://www.meticulousresearch.com/request-sample-report/?cp_id=3221
The key players operating in the global cell culture market are Irvine Scientific, HiMedia Laboratories, Cell Culture Company LLC, Merck & Co., Incorporation, GE Healthcare, Agilent Technologies, Thermo Fisher Scientific, PromoCell GmbH, Lonza, Corning Incorporation, Becton Dickinson , CellGenix GmbH , InvivoGen, Sera Care Life Sciences Incorporation, and American Type Culture Collection.
Scope:
Market by Product
- Consumables
• Media
• Reagents
• Sera - Media
• Synthetic Media
• Classical Media
• Natural Media
• Speciality Media
• Stem Cell Media - Synthetic Media
• Serum Free Media
• Chemically Defined Media
• Protein Free media
• Xeno Free Media
• Serum Containing Media - Natural Media
• Biological Fluids
• Tissue Extracts
• Coagulants or Clots - Reagents
• Growth Factors and Cytokines
• Cryopreservatives
• Subculturing Reagents
• Protease Inhibitors
• Antibiotics
• Buffers
• Attached and Matrix Factors
• Amino Acids
• Balanced Salt Solutions
• Others - Sera
• Fetal Bovine Serum
• New Born Calf Serum
• Other Animal Sera - Instruments
• Sterilizers
• Bioreactors
• Biosafety Cabinets
• Carbon Dioxide Incubator
• Cryopreservatives Tanks
• Centrifuges
• Microscopes
• Cell Counters
• Pipetting Instruments
• Cell Culture Vessels - Cell Culture Vessels
• Culture Dishes
• T-Flasks
• Roller Bottles
• Culture Plates
• Culture Bags
Market by Application
- Vaccination
- Recombinant Products
- Cancer Research
- Drug Screening & Development
- Toxicity Testing
- Stem Cell Technology
- Regenerative Medicines
- Others
Market by End User
- Pharmaceutical and Biotechnology Industry
- Academic Institutes
- Research Centers
For more information visit
http://www.meticulousresearch.com/product/cell-culture-market-size-2022/
Contact Info-
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 



